The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Dugel Pravin | See Remarks, Director | Gift(G) | 50K | — | $0 |
| Jun 16, 2026 | Dugel Pravin | See Remarks, Director | Gift(G) | 50K | — | $0 |
| Jun 10, 2026 | Williams Leslie J. | Director | Grant(A) | 14K | — | $0 |
| Jun 10, 2026 | Williams Leslie J. | Director | Grant(A) | 44K | — | $0 |
| Jun 10, 2026 | Graves Adrienne L | Director | Grant(A) | 14K | — | $0 |
| Jun 10, 2026 | Graves Adrienne L | Director | Grant(A) | 44K | — | $0 |
| Jun 10, 2026 | Robins Jason Shand | Chief Financial Officer | Grant(A) | 15K | — | $0 |
| Jun 10, 2026 | Robins Jason Shand | Chief Financial Officer | Grant(A) | 14K | — | $0 |
| Jun 10, 2026 | Hong Seung Suh | Director | Grant(A) | 14K | — | $0 |
| Jun 10, 2026 | Hong Seung Suh | Director | Grant(A) | 44K | — | $0 |
| Jun 10, 2026 | Warden Charles M | Director | Grant(A) | 14K | — | $0 |
| Jun 10, 2026 | Warden Charles M | Director | Grant(A) | 44K | — | $0 |
| Jun 10, 2026 | Lindstrom Richard L MD | Director | Grant(A) | 14K | — | $0 |
| Jun 10, 2026 | Lindstrom Richard L MD | Director | Grant(A) | 44K | — | $0 |
| Jun 10, 2026 | Raines Merilee | Director | Grant(A) | 14K | — | $0 |
| Jun 10, 2026 | Raines Merilee | Director | Grant(A) | 44K | — | $0 |
| Jun 3, 2026 | Waheed Nadia | Chief Medical Officer | Sell(S) | 15K | $8.27 | $123K |
| May 28, 2026 | Dugel Pravin | See Remarks, Director | Gift(G) | 395K | — | $0 |
| May 28, 2026 | Dugel Pravin | See Remarks, Director | Gift(G) | 395K | — | $0 |
| May 26, 2026 | Heier Jeffrey S. | Chief Scientific Officer | Sell(S) | 3K | $8.20 | $25K |
| May 26, 2026 | Nayak Sanjay | Chief Strategy Officer | Sell(S) | 2K | $8.20 | $15K |
| May 26, 2026 | Kaiser Peter | Chief Development Officer | Sell(S) | 3K | $8.20 | $24K |
| May 26, 2026 | Dugel Pravin | See Remarks, Director | Sell(S) | 21K | $8.20 | $173K |
| Apr 9, 2026 | Dugel Pravin | See Remarks, Director | Gift(G) | 395K | — | $0 |
| Apr 9, 2026 | Dugel Pravin | See Remarks, Director | Gift(G) | 395K | — | $0 |
| Feb 23, 2026 | Nayak Sanjay | Chief Strategy Officer | Sell(S) | 2K | $8.28 | $15K |
| Feb 23, 2026 | Heier Jeffrey S. | Chief Scientific Officer | Sell(S) | 3K | $8.28 | $25K |
| Feb 23, 2026 | Kaiser Peter | Chief Development Officer | Sell(S) | 3K | $8.28 | $23K |
| Feb 23, 2026 | Dugel Pravin | See Remarks, Director | Sell(S) | 20K | $8.28 | $166K |
| Feb 20, 2026 | Lindstrom Richard L MD | Director | Buy(P) | 60K | $7.66 | $461K |
| Feb 20, 2026 | Waheed Nadia | Chief Medical Officer | Sell(S) | 4K | $7.74 | $27K |
| Feb 12, 2026 | Waheed Nadia | Chief Medical Officer | Sell(S) | 8K | $9.04 | $71K |
| Feb 12, 2026 | Dugel Pravin | See Remarks, Director | Sell(S) | 125K | $9.04 | $1.1M |
| Feb 12, 2026 | Nayak Sanjay | Chief Strategy Officer | Sell(S) | 10K | $9.04 | $94K |
| Feb 12, 2026 | Notman Donald | Chief Operating Officer | Sell(S) | 11K | $9.04 | $103K |
| Feb 4, 2026 | Notman Donald | Chief Operating Officer | Sell(S) | 6K | $8.54 | $52K |
| Feb 2, 2026 | Notman Donald | Chief Operating Officer | Sell(S) | 5K | $9.14 | $50K |
| Jan 21, 2026 | Robinson David Wayne | Global CCO | Grant(A) | 136K | — | $0 |
| Jan 21, 2026 | Robinson David Wayne | Global CCO | Grant(A) | 416K | — | $0 |
| Jan 20, 2026 | Robins Jason Shand | Interim CFO | Grant(A) | 33K | — | $0 |
| Jan 2, 2026 | Notman Donald | See Remarks | Grant(A) | 79K | — | $0 |
| Jan 2, 2026 | Notman Donald | See Remarks | Grant(A) | 241K | — | $0 |
| Jan 2, 2026 | Heier Jeffrey S. | Chief Scientific Officer | Grant(A) | 79K | — | $0 |
| Jan 2, 2026 | Heier Jeffrey S. | Chief Scientific Officer | Grant(A) | 241K | — | $0 |
| Jan 2, 2026 | Waheed Nadia | Chief Medical Officer | Grant(A) | 79K | — | $0 |
| Jan 2, 2026 | Waheed Nadia | Chief Medical Officer | Grant(A) | 241K | — | $0 |
| Jan 2, 2026 | Saroj Namrata | Chief Business Officer | Grant(A) | 79K | — | $0 |
| Jan 2, 2026 | Saroj Namrata | Chief Business Officer | Grant(A) | 241K | — | $0 |
| Jan 2, 2026 | Kaiser Peter | Chief Development Officer | Grant(A) | 79K | — | $0 |
| Jan 2, 2026 | Kaiser Peter | Chief Development Officer | Grant(A) | 241K | — | $0 |
| Jan 2, 2026 | Nayak Sanjay | Chief Strategy Officer | Grant(A) | 65K | — | $0 |
| Jan 2, 2026 | Nayak Sanjay | Chief Strategy Officer | Grant(A) | 198K | — | $0 |
| Jan 2, 2026 | Meyers Steve Lawrence | Chief Commercial Officer | Grant(A) | 65K | — | $0 |
| Jan 2, 2026 | Meyers Steve Lawrence | Chief Commercial Officer | Grant(A) | 198K | — | $0 |
| Jan 2, 2026 | Anderman Todd | Chief Legal Officer | Grant(A) | 65K | — | $0 |
| Jan 2, 2026 | Anderman Todd | Chief Legal Officer | Grant(A) | 198K | — | $0 |
| Nov 26, 2025 | Dugel Pravin | See Remarks, Director | Gift(G) | 50K | — | $0 |
| Nov 26, 2025 | Dugel Pravin | See Remarks, Director | Gift(G) | 50K | — | $0 |
| Nov 24, 2025 | Heier Jeffrey S. | Chief Scientific Officer | Sell(S) | 3K | $12.04 | $42K |
| Nov 24, 2025 | Kaiser Peter | Chief Development Officer | Sell(S) | 3K | $12.02 | $36K |
| Nov 24, 2025 | Dugel Pravin | See Remarks, Director | Sell(S) | 20K | $12.04 | $235K |
| Nov 24, 2025 | Nayak Sanjay | Chief Strategy Officer | Sell(S) | 2K | $12.04 | $23K |
| Nov 5, 2025 | Saroj Namrata | Chief Business Officer | Sell(S) | 26K | $10.74 | $278K |
| Oct 8, 2025 | Anderman Todd | Chief Legal Officer | Sell(S) | 11K | $12.34 | $137K |
| Oct 2, 2025 | Heier Jeffrey S. | Chief Scientific Officer | Sell(S) | 11K | $11.04 | $116K |
| Oct 2, 2025 | Kaiser Peter | Chief Development Officer | Sell(S) | 10K | $11.03 | $106K |
| Sep 9, 2025 | Dugel Pravin | See Remarks, Director | Gift(G) | 50K | — | $0 |
| Sep 9, 2025 | Dugel Pravin | See Remarks, Director | Gift(G) | 50K | — | $0 |
| Sep 2, 2025 | Notman Donald | See Remarks | Sell(S) | 1K | $12.43 | $13K |
| Aug 25, 2025 | Dugel Pravin | See Remarks, Director | Sell(S) | 21K | $12.04 | $259K |
| Aug 25, 2025 | Heier Jeffrey S. | Chief Scientific Officer | Sell(S) | 3K | $12.04 | $37K |
| Aug 25, 2025 | Nayak Sanjay | Chief Strategy Officer | Sell(S) | 2K | $12.04 | $23K |
| Aug 25, 2025 | Kaiser Peter | Chief Development Officer | Sell(S) | 3K | $12.04 | $36K |
| Aug 12, 2025 | Waheed Nadia | Chief Medical Officer | Grant(A) | 40K | — | $0 |
| Aug 12, 2025 | Waheed Nadia | Chief Medical Officer | Grant(A) | 123K | — | $0 |
| Aug 11, 2025 | Dugel Pravin | See Remarks, Director | Gift(G) | 250K | — | $0 |
| Jun 12, 2025 | Dugel Pravin | See Remarks, Director | Gift(G) | 50K | — | $0 |
| Jun 11, 2025 | Graves Adrienne L | Director | Grant(A) | 14K | — | $0 |
| Jun 11, 2025 | Graves Adrienne L | Director | Grant(A) | 44K | — | $0 |
| Jun 11, 2025 | Warden Charles M | Director | Grant(A) | 14K | — | $0 |
| Jun 11, 2025 | Warden Charles M | Director | Grant(A) | 44K | — | $0 |
| Jun 11, 2025 | Williams Leslie J. | Director | Grant(A) | 14K | — | $0 |
| Jun 11, 2025 | Williams Leslie J. | Director | Grant(A) | 44K | — | $0 |
| Jun 11, 2025 | Lindstrom Richard L MD | Director | Grant(A) | 14K | — | $0 |
| Jun 11, 2025 | Lindstrom Richard L MD | Director | Grant(A) | 44K | — | $0 |
| Jun 11, 2025 | Raines Merilee | Director | Grant(A) | 14K | — | $0 |
| Jun 11, 2025 | Raines Merilee | Director | Grant(A) | 44K | — | $0 |
| Jun 11, 2025 | Hong Seung Suh | Director | Grant(A) | 14K | — | $0 |
| Jun 11, 2025 | Hong Seung Suh | Director | Grant(A) | 44K | — | $0 |
| Jun 11, 2025 | Dugel Pravin | See Remarks, Director | Grant(A) | 2.8M | — | $0 |
| Jun 2, 2025 | Waheed Nadia | Chief Medical Officer | Sell(S) | 14K | $8.05 | $112K |
| May 23, 2025 | Dugel Pravin | See Remarks, Director | Sell(S) | 21K | $7.18 | $152K |
| May 23, 2025 | Heier Jeffrey S. | Chief Scientific Officer | Sell(S) | 3K | $7.18 | $22K |
| May 23, 2025 | Kaiser Peter | Chief Development Officer | Sell(S) | 3K | $7.17 | $21K |
| May 23, 2025 | Nayak Sanjay | Chief Strategy Officer | Sell(S) | 2K | $7.17 | $13K |
| May 8, 2025 | Lindstrom Richard L MD | Director | Buy(P) | 10K | $6.96 | $70K |
| Apr 28, 2025 | Dugel Pravin | See Remarks, Director | Gift(G) | 200K | — | $0 |
| Feb 24, 2025 | Nayak Sanjay | Chief Strategy Officer | Sell(S) | 2K | $6.84 | $13K |
| Feb 24, 2025 | Kaiser Peter | Chief Development Officer | Sell(S) | 3K | $6.87 | $21K |
| Feb 24, 2025 | Heier Jeffrey S. | Chief Scientific Officer | Sell(S) | 3K | $6.87 | $21K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).